Do UK Clinics Show Product Catalogues to Patients Now?

Estimated reading time shown on page: 4 minutes

Since the landmark legal changes in 2018 that effectively birthed the UK's medical cannabis market, a new ecosystem has evolved rapidly, creating opportunities and challenges for clinics, patients, and suppliers alike. One frequently asked question is whether UK clinics today present clinic product catalogues directly to patients, especially relating to patient facing medical cannabis options. This blog post explores the current landscape, highlighting the roots of the market, the complexities around prescription-gated demand, the infrastructure built from scratch, and how competitive pressures shape clinic practices.
The 2018 Legal Change and the Birth of the Medical Cannabis Market
Before November 2018, medical cannabis was effectively unavailable via NHS prescriptions in the UK. The rescheduling of cannabis-based products for medicinal use (CBPM) to a legal status enabled specialist clinics to prescribe under strict regulation. This change sparked the birth of a patient-facing medical cannabis market almost overnight.

However, this was not a simple case of supply meeting demand immediately. Clinics and suppliers faced a near-clean slate. Without precedent, they needed to establish entirely new approaches to patient engagement, prescription handling, and product transparency.
Foundation of the Market Infrastructure
Unlike standard consumer markets, medical cannabis clinics had to build their patient interaction frameworks, digital platforms, and regulatory compliance processes from scratch. A striking feature is how many clinics today use WordPress to power their websites. The presence of categorized blog posts and a structured online shop in many instances reveals attempts to harmonise educational content with product listings.

For example, some clinics separate product information under WordPress categories that reflect different cannabis strains, formulations, or delivery methods — essentially building the clinic product catalogue UK experience on familiar digital foundations.
Prescription-Gated Demand: The Unique Constraint
One of the defining characteristics of patient access to medical cannabis in the UK is that demand is prescription-gated. Patients cannot self-prescribe, and even GPs generally do not issue direct prescriptions outside specialist clinics. This caution and gatekeeping create a market dynamic unlike conventional pharmaceutical or OTC products.
Clinics must assess patients thoroughly before prescribing. Products available are often restricted to licensed suppliers complying with MHRA regulations. Patient education is paramount but must remain compliant with advertising restrictions on controlled drugs.
These factors influence whether clinics choose to openly display product catalogues. Presenting a full product list can be helpful for patients to understand options but risks being interpreted as promotional or sales-driven, which regulators scrutinize.
Example: The Releaf Product List
A practical example is the Releaf product list example, often shared by clinics or suppliers to educate patients on available medical cannabis formulations. This list provides detailed insights into cannabinoid profiles, strengths, and types, assisting patients in navigating choices before consultation.

While clinics might not publish such detailed lists publicly because of regulatory caution, components of these lists typically appear in patient consultations and dedicated patient portals.
Building Infrastructure from Scratch: Digital Marketing and Information Delivery
Alongside clinics, companies like GC Associates LLP and GC Digital Marketing have played critical roles in helping establish patient outreach and digital presence. Their expertise supports:
Developing compliant websites using platforms like WordPress. Curating regulated blog content to inform patients about medical cannabis. Integrating RSS feeds for real-time news or product updates, helping clinics stay connected with ongoing market and regulatory evolutions.
Because the ecosystem had no pre-existing templates, these entities effectively co-created the technical and marketing infrastructure needed to communicate complex product information clearly and legally.
Ecosystem Roles and Competitive Pressures
The UK medical cannabis ecosystem now includes:
Clinics, which consult and prescribe. Specialist pharmacies fulfilling prescriptions. Licensed suppliers providing a range of cannabis products. Marketing and compliance professionals ensuring accurate, patient-focused communication.
Competitive pressure exists among clinics to demonstrate comprehensive patient care, including transparent options. However, balancing transparency with strict compliance is a constant challenge. This often means a more personalised approach to sharing product catalogues—such as detailed brochures available post-consultation or secure patient portals—rather than publicly broadcasting exhaustive product lists.
Business Case Studies: Learning From the Market
Research and Business Case Studies indicate that clinics embracing robust patient education combined with strategic digital infrastructure tend to build more sustainable patient trust. Simple, accessible product catalogues that align with compliance requirements can be a differentiator in a competitive marketplace.
Conclusion: Are Clinics Showing Product Catalogues to Patients Now?
Yes and no. UK clinics increasingly provide patients with access to medical cannabis product catalogues, but in carefully controlled formats that respect the prescription-gated environment and regulatory framework. Public websites often offer educational content and selective product overviews rather than exhaustive lists. More detailed clinic product catalogue UK offerings tend to be delivered:
During patient consultations; Within secure patient portals; Via regulated communication channels managed by marketing specialists such as GC Digital Marketing.
The market continues to https://businesscasestudies.co.uk/the-uk-medical-cannabis-market-a-business-case-study-in-a-newly-legal-industry/ evolve, supported by organisations like GC Associates LLP who help clinics adapt digital infrastructures such as WordPress-driven sites and RSS content feeds to stay ahead in compliance and patient engagement.

For patients navigating patient facing medical cannabis options in the UK, understanding this evolving landscape—and knowing that product catalogues are increasingly being presented as part of comprehensive care—can help in making informed treatment decisions.
Further Reading & Resources GC Associates LLP Website GC Digital Marketing Business Case Studies – Healthcare Sector Examples WordPress Healthcare Websites Showcase